drugset / Trial / NCT04528758
F-18 Rhodamine 6G PET Imaging for Myocardial Blood Flow
Phase 0
Suspended
15 enrolled
Washington University School of Medicine
Boston Children's Hospital · collab
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
Use of novel radio-pharmaceutical Rhodamine 6G to determine myocardial blood flow
Timeline
- Start
- 2018-10-16
- Primary completion
- 2024-06
- Completion
- 2024-12
Outcome
Outcome not reported
Stopped: “re-evaluation of radiotracer”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Basic red 1 | Small molecule | — | — |